CSL Behring (Australia) Pty Ltd
$5.75 billion
Lifetime federal contract value awarded across 12 contract notices.
- ABN
- 48160734761
- Country
- AUSTRALIA
- State
- VIC
Awarded by financial year
- 2015-16$0
- 2016-17$0
- 2017-18$3,351,400,190
- 2018-19$30,898,181
- 2019-20$165,000,000
- 2020-21$1,874,602,219
- 2021-22$0
- 2022-23$254,215,600
- 2023-24$0
- 2024-25$0
- 2025-26$73,656,150
- 2026-27$0
Top agencies awarded to this supplier
- National Blood Authority$5,749,718,022
- Department of Defence$54,317
Contracts (12)
Click any CN ID to verify the contract notice on AusTender.
- $23,279Department of DefencePharmaceutical ProductsPublished 28 Apr 2026
- $10,346Department of DefencePathology ProductsPublished 20 Apr 2026
- $10,346Department of DefencePathology ProductsPublished 13 Oct 2025
- $10,346Department of DefencePathology ProductsPublished 24 Sept 2025
- $1,874,602,219National Blood AuthorityNational Supply arrangement for imported immunoglobulin productsPublished 4 Sept 2025
- $73,601,833National Blood AuthorityProcurement of Imported Plasma and Recombinant Products (IPRP) - IdelvionPublished 18 July 2025
- $246,647,977National Blood AuthorityImported Plasma and Recombinant ProductsPublished 2 Nov 2022
- $7,567,623National Blood AuthorityImported Plasma and Recombinant Products (Factor XI Concentrate)Published 2 Nov 2022
- CN3277493-A2amendment$165,000,000National Blood AuthoritySupply of imported immunoglobulin productsPublished 15 Jan 2020 · Comprehensive health services
- CN3383763-A2amendment$28,394,823National Blood AuthoritySupply of Imported Plasma and Recombinant Products (IPRP)Published 14 May 2019 · Comprehensive health services
- CN3394011-A1amendment$2,503,358National Blood AuthoritySupply of Imported Plasma and Recombinant ProductsPublished 15 Apr 2019 · Comprehensive health services
- $3,351,400,190National Blood AuthorityNational Fractionation AgreementPublished 10 Jan 2018
| CN ID | Agency | Description | ||
|---|---|---|---|---|
| CN4235262 | Department of Defence | Pharmaceutical Products | 28 Apr 2026 | $23,279 |
| CN4233600 | Department of Defence | Pathology Products | 20 Apr 2026 | $10,346 |
| CN4194214 | Department of Defence | Pathology Products | 13 Oct 2025 | $10,346 |
| CN4190631 | Department of Defence | Pathology Products | 24 Sept 2025 | $10,346 |
| CN3743070 | National Blood Authority | National Supply arrangement for imported immunoglobulin products | 4 Sept 2025 | $1,874,602,219 |
| CN4171514 | National Blood Authority | Procurement of Imported Plasma and Recombinant Products (IPRP) - Idelvion | 18 July 2025 | $73,601,833 |
| CN3924655 | National Blood Authority | Imported Plasma and Recombinant Products | 2 Nov 2022 | $246,647,977 |
| CN3924656 | National Blood Authority | Imported Plasma and Recombinant Products (Factor XI Concentrate) | 2 Nov 2022 | $7,567,623 |
| CN3277493-A2amendment | National Blood Authority | Supply of imported immunoglobulin products Comprehensive health services | 15 Jan 2020 | $165,000,000 |
| CN3383763-A2amendment | National Blood Authority | Supply of Imported Plasma and Recombinant Products (IPRP) Comprehensive health services | 14 May 2019 | $28,394,823 |
| CN3394011-A1amendment | National Blood Authority | Supply of Imported Plasma and Recombinant Products Comprehensive health services | 15 Apr 2019 | $2,503,358 |
| CN3479056 | National Blood Authority | National Fractionation Agreement | 10 Jan 2018 | $3,351,400,190 |
Sources
Department of Finance · 2013 onward · CC-BY 3.0 AU
Each row above can be verified by clicking the CN ID to view the source notice on AusTender. Methodology at /methodology/#contracts.
Refreshed 1 July 2026 · Caveats